Additionally, an association between obesity and obesity-related comorbidities was established, indicating an increased risk of comorbidity as BMI rises, and the cost of treating and managing obesity in the KSA was estimated to be $6.4 billion (133)
Tc Dng V Lu S Dng 7
(BMI 30+, or BMI 27+ with a weight-related condition, or type 2 diabetes) If yes, proceed
AEs: GLP-1 RAs showed a trend toward an increased risk of AEs across multiple populations
When glutathione is taken in a higher dosage, the pathway of melanin is altered and is proven to reverse the melanins metabolism turning dark pigmentations (eumelanin) into light pigmentations (phaeomelanin) by inhibiting and blocking the Tyrosinase enzyme
Diabetes Ther 7:411438 Lau J, Bloch P, Schaffer L et al (2015) Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide